Results for tag: "Peptide Vaccine"

The Peptide Vaccine market is a subset of the Vaccines market, which is a rapidly growing industry. Peptide Vaccines are a type of vaccine that use peptides, or short chains of amino acids, to stimulate an immune response. They are designed to target specific antigens, and are often used to treat chronic diseases such as cancer and autoimmune disorders. Peptide Vaccines are also being developed to target infectious diseases, such as influenza and malaria. Peptide Vaccines are attractive to pharmaceutical companies due to their low cost and ease of production. They are also seen as a safer alternative to traditional vaccines, as they are less likely to cause adverse reactions. Additionally, they can be tailored to target specific antigens, making them more effective than traditional vaccines. Some companies in the Peptide Vaccine market include GlaxoSmithKline, Merck, Sanofi, and Pfizer. Other companies, such as Novavax and Moderna, are also developing peptide-based vaccines. Show Less Read more